318 related articles for article (PubMed ID: 21634361)
1. Complete regression of retinoblastoma following intra-arterial chemotherapy.
Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
[TBL] [Abstract][Full Text] [Related]
2. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
Hutchinson A; Kaliki S; Shields CL
J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587
[TBL] [Abstract][Full Text] [Related]
3. Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.
De Freytas A; Harto-Castaño M; Barranco H; Aviño J; Martinez-Costa R
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):487-90. PubMed ID: 26008929
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
Vajzovic LM; Murray TG; Aziz-Sultan MA; Schefler AC; Fernandes CE; Wolfe SC; Hess DJ; Dubovy SR
Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791
[No Abstract] [Full Text] [Related]
5. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.
Hadjistilianou T; Coriolani G; Bracco S; Gennari P; Caini M; Cerase A; Galimberti D; De Francesco S; De Luca M; Mastrangelo D
J Pediatr Ophthalmol Strabismus; 2014; 51(1):32-8. PubMed ID: 24308859
[TBL] [Abstract][Full Text] [Related]
7. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
8. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.
Fallaha N; Dubois J; Carret AS; Callejo SA; Hamel P; Superstein R
Arch Ophthalmol; 2012 Aug; 130(8):1075-7. PubMed ID: 22893086
[No Abstract] [Full Text] [Related]
9. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
Padrón-Pérez N; Català-Mora J
J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
[No Abstract] [Full Text] [Related]
10. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
11. Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; López Briz E; Escobar Cava P; Balaguer J; Pelufo A; Megías JE; Poveda Andrés JL
J Oncol Pharm Pract; 2013 Jun; 19(2):159-64. PubMed ID: 23014898
[TBL] [Abstract][Full Text] [Related]
12. Ocular dysmotility after intra-arterial chemotherapy for retinoblastoma.
Lambert NG; Winegar BA; Feola GP; Ramasubramanian A
J AAPOS; 2015 Dec; 19(6):574-7. PubMed ID: 26691048
[TBL] [Abstract][Full Text] [Related]
13. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
14. Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.
Materin MA; Kuzmik GA; Jubinsky PT; Minja FJ; Asnes JD; Bulsara KR
J Neurointerv Surg; 2013 Nov; 5(6):e42. PubMed ID: 23188789
[TBL] [Abstract][Full Text] [Related]
15. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.
Aziz HA; Boutrid H; Murray TG; Berrocal A; Wolfe SQ; Pina Y; Dorfman M; Moftakhar R; Fernandes CE; Reichbach J; Aziz-Sultan MA
Retina; 2010 Apr; 30(4 Suppl):S63-5. PubMed ID: 20224464
[TBL] [Abstract][Full Text] [Related]
16. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
Rojanaporn D; Kaliki S; Bianciotto CG; Iturralde JC; Say EA; Shields CL
Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
18. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
